Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Fibrosis Myocardial

Tundra lists 3 Fibrosis Myocardial clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT03586518

Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients

There are currently no good ways of measuring levels of scarring in the hearts of patients with advanced kidney disease and patients on dialysis, although recent research has shown a new cardiac MRI technique, called native T1 mapping, may provide a solution to this. To assess the accuracy of this novel technique in dialysis patients, it is essential to undertake a study which compares native T1 mapping to actual levels of scarring in the hearts of patients on dialysis.

Gender: All

Ages: 18 Years - Any

Updated: 2025-04-18

1 state

End Stage Kidney Disease
Fibrosis Myocardial
RECRUITING

NCT05241418

Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease

In this research study the investigators want to learn more about how well the investigators can visualize scar tissue in the heart by MRI. In patients with congenital heart disease who need a procedure in the electrophysiology laboratory, how the MRI findings match the findings in the electrophysiology laboratory is not known. This study works to answer these questions. Participants will undergo a cardiac MRI as part of the routine clinical care that was ordered by their doctors and additional imaging by cardiac MRI will be performed.

Gender: All

Ages: 13 Years - Any

Updated: 2025-02-13

1 state

Congenital Heart Disease
Fibrosis Myocardial
Fibrosis; Heart
NOT YET RECRUITING

NCT03993730

Cardiovascular Magnetic Resonance GUIDEd Insertion of Implantable Cardiac Defibrillator in Dilated CardioMyopathy

CMR GUIDE DCM is a randomized controlled trial with a registry for non-randomized patients. Patients enrolled will have non-ischemic cardiomyopathy (NICM) with mild to severe Left Ventricular (LV) systolic dysfunction with replacement fibrosis identified on Cardiac Magnetic Resonance (CMR). 954 patients will be randomised from 50 sites across 4-6 countries worldwide to receive an implantable defibrillator (ICD) or implantable loop recorder (ILR). Device and clinical follow-up will be performed at 3, 6, 12, 24, 36 months and at end of study.

Gender: All

Ages: 18 Years - Any

Updated: 2019-06-21

Dilated Cardiomyopathy
Left Ventricular Systolic Dysfunction
Fibrosis Myocardial